Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients

European Journal of Pharmaceutical Sciences

Volumn 24, Issue 4, 2005, Pages 271-279

  Ha, Huy Riem ^a   Bigler, Laurent ^b   Wendt, Barbara ^b,c   Maggiorini, Marco ^a   Follath, Ferenc ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SÜD CHEMIE AG   (Germany)

Author keywords

Human plasma concentrations; Quantification; Tandem mass spectrometry

Indexed keywords

3' HYDROXY N DESETHYLAMIODARONE; AMIODARONE; DIDEETHYLAMIODARONE; DRUG METABOLITE; MORPHOLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOTRANSFORMATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEALKYLATION; DEAMINATION; DEIODINATION; DRUG BLOOD LEVEL; DRUG IDENTIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROXYLATION; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 14144256218     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2004.10.015     Document Type: Article

References (25)

1. P.C. Adams, D.W. Holt, G.C. Storey, A.R. Morley, J. Callaghan, and R.W. Campbell Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy Circulation 72 1985 1064 1075
2. J.F. Brien, S. Jimmo, F.J. Brennan, S.E. Ford, and P.W. Armstrong Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues Can. J. Physiol. Pharmacol. 65 1987 360 364
3. J. Broekhuysen, R. Laruel, and R. Sion Recherches dans la serie des benzofurannes. XXXVII. Etude comparee du transit et du metabolisme de l'amiodarone chez diverses especes animales et chez l'homme. (Research on the benzofuran series. XXXVII. Comparative study of transit and metabolism of amiodarone in different species of animals and humans) Arch. Int. Pharmacodyn. Ther. 177 1969 340 359
4. G. Dickstein, S. Amikam, E. Riss, and D. Barzilai Thyrotoxicosis induced by amiodarone, a new efficient antiarrhythmic drug with high iodine content Am. J. Med. Sci. 288 1984 14 17
5. A.T. Elvin, J.B. Keenaghan, E.W. Byrnes, P.A. Tenthorey, P.D. McMaster, B.H. Takman, D. Lalka, C.V. Manion, D.T. Baer, E.M. Wolshin, M.B. Meyer, and R.A. Ronfeld Tocainide conjugation in humans: novel biotransformation pathway for a primary amine J. Pharm. Sci. 69 1980 47 49
6. G. Fabre, B. Julian, B. Saint-Aubert, H. Joyeux, and Y. Berger Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions Drug Metab. Dispos. 21 1993 978 985
7. R.J. Flanagan, G.C. Storey, D.W. Holt, and P.B. Farmer Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients J. Pharm. Pharmacol. 34 1982 638 643
8. H.R. Ha, L. Bigler, M. Binder, P. Kozlik, B. Stieger, M. Hesse, H.R. Altorfer, and F. Follath Metabolism of amiodarone (part I): identification of a new hydroxylated metabolite of amiodarone Drug Metab. Dispos. 29 2001 152 158
9. H.R. Ha, B. Stieger, G. Grassi, H.R. Altorfer, and F. Follath Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination Eur. J. Clin. Pharmacol. 55 2000 807 814
10. H.R. Ha, P.A. Wyss, B. Stieger, U.A. Meyer, and F. Follath Amiodarone metabolism in human microsomes FASEB J. 6 1992 A1845 Abstract
11. J.J. Heger, E.N. Prystowsky, and D.P. Zipes Relationships between amiodarone dosage, drug concentrations, and adverse side effects Am. Heart J. 106 1983 931 935
12. J.J. Heger, E.B. Solow, E.N. Prystowsky, and D.P. Zipes Plasma and red blood cell concentrations of amiodarone during chronic therapy Am. J. Cardiol. 53 1984 912 917
13. D. Hilleman, M.A. Miller, R. Parker, P. Doering, and J.A. Pieper Optimal management of amiodarone therapy: efficacy and side effects Pharmacotherapy 18 1998 138S 145S
14. U.M. Joshi, P.R. Kodavanti, B. Coudert, T.M. Dwyer, and H.M. Mehendale Types of interaction of amphiphilic drugs with phospholipid vesicles J. Pharmacol. Exp. Ther. 246 1988 150 157
15. D.G. Julian, A.J. Camm, G. Frangin, M.J. Janse, A. Munoz, P.J. Schwartz, and P. Simon Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT - European Myocardial Infarct Amiodarone Trial Investigators Lancet 349 1997 667 674
16. Kozlik, P., 2003. Metabolism of Amiodarone-Biotransformation of mono-N-Desethylamiodarone in vitro. Ph.D. Thesis Nr. 15287, ETH Zurich, Switzerland.
17. R. Latini, R. Reginato, A.L. Burlingame, and R.E. Kates High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of di-N-desethylamiodarone, a new metabolite of amiodarone in the dog Biomed. Mass Spectrom. 11 1984 466 471
18. F.E. Marchlinski, T.S. Gansler, H.L. Waxman, and M.E. Josephson Amiodarone pulmonary toxicity Ann. Intern. Med. 97 1982 839 845
19. J.W. Mason Amiodarone N. Engl. J. Med. 316 1987 455 466
20. C.N. Ou, C.L. Rognerud, L.T. Duong, and V.L. Frawley Liquid- chromatographic determination of amiodarone and N-desethylamiodarone in serum Clin. Chem. 36 1990 532 534
21. B. Rigas, L.E. Rosenfeld, K.W. Barwick, R. Enriquez, J. Helzberg, W.P. Batsford, M.E. Josephson, and C.A. Riely Amiodarone hepatotoxicity. A clinicopathologic study of five patients Ann. Intern. Med. 104 1986 348 351
22. W.H. Schaefer Formation of a carbamoyl glucuronide conjugate of carvedilol in vitro using dog and rat liver microsomes Drug Metab. Dispos. 20 1992 130 133
23. M. Staubli, A. Troendle, B. Schmid, P. Balmer, B. Kohler, H. Studer, and J. Bircher Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites Eur. J. Clin. Pharmacol. 29 1985 417 423
24. J.M. Trivier, C. Libersa, C. Belloc, and M. Lhermitte Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report) Life Sci. 52 1993 L91 L96
25. B. Wendt, H.R. Ha, and M. Hesse Synthesis of two metabolites of the antiarrhythmicum amiodarone Helv. Chim. Acta 85 2002 2990 3001